Profitelligence Profitelligence · Filing Ledger Open HOLX research →

Form 8-K · Current Report · Filed 2026-01-26

Hologic Announces Merger Agreement and Faces Related Litigation

Hologic, Inc. has entered into a merger agreement with Hopper Parent Inc., under which Hopper Merger Sub Inc. will merge with and into Hologic, with Hologic surviving as a wholly owned subsidiary of Hopper Parent. The transaction is subject to various conditions and stockholder approval. In connection with the merger, several purported stockholders have filed class action lawsuits and individual actions against Hologic and its board of directors, alleging omissions in the proxy statement regarding the merger. Hologic believes the allegations are without merit but is supplementing the proxy statement to mitigate the risk of litigation delaying the merger. Additionally, Hologic has initiated a voluntary recall of its Brevera Breast Biopsy System Disposable 9 Gauge Needles due to safety concerns, which may impact financial results. The Company has also settled a product liability lawsuit related to its BioZorb 3D Bioabsorbable Marker, with the settlement amount covered by insurance.

Filer
Hologic Inc. HOLX · NASDAQ
Filed
Accession
0001193125-26-022672
CIK
0000859737
Signal
High impactHealthcare

Items reported

Item events

Reported Item

M&A Transaction Lawsuit Filed Product Launch

Market reaction

Close before filing

$75.05

Next session

+0.2%

Since filing

+1.3%

Latest close

$76.01

What happened, not what will happen — closing prices around the filing date.

About Hologic Inc.

Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.

Exchange NASDAQ Industry Medical Instruments & Supplies Company website ↗

Never miss another HOLX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts